Significance of survivin and PTEN expression in full lymph node-examined gastric cancer

World Journal of Gastroenterology

Volumn 12, Issue 7, 2006, Pages 1013-1017

  Deng, Hao ^a,b   Wu, Ren Liang ^b   Zhou, Hong Yan ^a   Huang, Xuan ^a   Chen, Ying ^a   Liu, Li Jiang ^a  

^a JIANGHAN UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Gastric cancer; PTEN; Survivin; Tissue micro array

Indexed keywords

MOLECULAR MARKER; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; SURVIVIN;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER INVASION; CHI SQUARE TEST; CHINA; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; FISHER EXACT TEST; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; KAPLAN MEIER METHOD; LOG RANK TEST; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN MICROARRAY; STOMACH CANCER;

EID: 33645102673     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v12.i7.1013     Document Type: Article

References (24)

1. Liu T, Wang XY, Song WJ, Zhu CZ, Li Y. Incidence of gastric malignant tumors during the past 20 years in Tianjin [J]. Shijie Huaren Xiaohua Zazhi 2004; 12: 20-22
2. Lauwers GY, Scott GV, Karpeh MS. Immunohistochemical evaluation of bcl-2 protein expression in gastric adenocarcinomas. Cancer 1995; 75: 2209-2213
3. Li F, Ambrosini G, Chu EY, Plescia J, Tognin S, Marchisio PC, Altieri DC. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature 1998; 396: 580-584
4. Ambrosini G, Adida C, Altieri DC. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma. Nat Med 1997; 3: 917-921
5. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, Puc J, Miliaresis C, Rodgers L, McCombie R, Bigner SH, Giovanella BC, Ittmann M, Tycko B, Hibshoosh H, Wigler MH, Parsons R. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer. Science 1997; 275: 1943-1947
6. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, Langford LA, Baumgard ML, Hattier T, Davis T, Frye C, Hu R, Swedlund B, Teng DH, Tavtigian SV. Identification of a candidate tumour suppressor gene, MMAC1, at chromosome 10q23.3 that is mutated in multiple advanced cancers. Nat Genet 1997; 15: 356-362
7. Li DM, Sun H. TEP1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosine phosphatase regulated by transforming growth factor beta. Cancer Res 1997; 57: 2124-2129
8. Maehama T, Taylor GS, Dixon JE. PTEN and myotubularin: novel phosphoinositide phosphatases. Annu Rev Biochem 2001; 70: 247-279
9. Besson A, Robbins SM, Yong VW. PTEN/MMAC1/TEP1 in signal transduction and tumorigenesis. Eur J Biochem 1999; 263: 605-611
10. Waite KA, Eng C. Protean PTEN: form and function. Am J Hum Genet 2002; 70: 829-844
11. Liu LJ, Zhang YT. The clinical research of lymph node metastasis in gastric cancer. Zhonghua Shiyan Waike Zazhi 1995; 12: 91-92
12. Kang JY, Dolled-Filhart M, Ocal IT, Singh B, Lin CY, Dickson RB, Rimm DL, Camp RL. Tissue microarray analysis of hepatocyte growth factor/Met pathway components reveals a role for Met, matriptase, and hepatocyte growth factor activator inhibitor 1 in the progression of node-negative breast cancer. Cancer Res 2003; 63: 1101-1105
13. Reed JC, Bischoff JR. BIRinging chromosomes through cell division - and survivin' the experience. Cell 2000; 102: 545-548
14. Giodini A, Kallio MJ, Wall NR, Gorbsky GJ, Tognin S, Marchisio PC, Symons M, Altieri DC. Regulation of microtubule stability and mitotic progression by survivin. Cancer Res 2002; 62: 2462-2467
15. Monzo M, Rosell R, Felip E, Astudillo J, Sanchezm JJ, Maestre J, Martin C, Font A, Barnadas A, Avad A. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers. J Clin Oncol 1999; 17: 2100-2104
16. Swana HS, Grossman D, Anthony JN, Weiss RM, Altieri DC. Tumor content of the antiapoptosis molecule survivin and recurrence of bladder cancer. N Engl J Med 1999; 341: 452-453
17. Adida C, Haioun C, Gaulard P, Lepage E, Morel P, Briere J, Dombret H, Reyes F, Diebold J, Gisselbrecht C, Salles G, Altieri DC, Molina TJ. Prognostic significance of survivin expression in diffuse large B-cell lymphomas. Blood 2000; 96: 1921-1925
18. Kato J, Kuwabara Y, Mitani M, Shinoda N, Sato A, Toyama T, Mitsui A, Nishiwaki T, Moriyama S, Kudo J, Fujii Y. Expression of survivin in esophageal cancer: correlation with the prognosis and response to chemotherapy. Int J Cancer 2001; 95: 92-95
19. Miyachi K, Fujita M, Tanaka N, Sasaki K, Sunagawa M. Correlation between telomerase activity and telomeric-repeat binding factors in gastric cancer. J Exp Clin Cancer Res 2002; 21: 269-275
20. Tsuburaya A, Noguchi Y, Yoshikawa T, Saito A, Doi C, Okamoto T, Fukuzawa K. An anti-apoptosis gene, survivin and telomerase expression in gastric cancer. Hepatogastroenterology 2002; 49: 1150-1152
21. Wang ZN, Xu HM, Jiang L, Zhou X, Lu C, Zhang X. Expression of survivin in primary and metastatic gastric cancer cells obtained by laser capture microdissection. World J Gastroenterol 2004; 10: 3094-3098
22. Zheng HC, Chen Y, Kuang LG, Yang L, Li JY, Wu DY, Zhang SM, and Xin Y. Expression of PTEN-encoding product in different stages of carcinogenesis and progression of gastric carcinoma. Zhonghua Zhongliu Zazhi 2003; 25: 13-16
23. Zheng HC, Chen Y, Kuang LG, Yang L, Li JY, Wu DY, Zhang SM, Xin Y. Expression of PTEN-encoding product in different stages of carcinogenesis and progression of gastric carcinoma. Zhonghua Zhongliu Zazhi 2003; 25: 13-16
24. Li H, Zhang XF, Wang C, Wu LM, Cai QF. Expression of tumor suppressor gene PTEN in human gastric carcinoma and its clinical significance. Shi Yong Zhong Liu Zazhi 2002; 17: 301-303